Abbott Laboratories chief Miles White (photo [1]) always ranks near the top of our executive compensation list, and it looks as if this year will be no exception. Although his total package declined by 7 percent in 2009, he still brought in $26.2 million worth of salary, bonus, stock awards, and the like.
White's base salary grew by about 3 percent to $1.85 million, and his stock awards jumped up 66 percent to almost $12.5 million. The value of his pension and deferred comp grew to $4.29 million. But the amount of stock options Abbott awarded him dropped by more than $7 million, to a bit over $3 million. That's a decline of 71 percent. His incentive plan cash also dropped slightly, to $3.9 million from $4.2 million.
If you look back at 2007, when White made about $32 million, the differences are even more striking: He got $14.77 million worth of options that year, compared with $3.016 million this year. The overall decline between 2007 to 2009: About 18 percent.
Now, last year White came in second place on our ranking behind Johnson & Johnson's Bill Weldon (photo [2]). Where will White stand this year? Looks like we won't know until we hear from J&J.
- check out the SEC filing [3]
- see the news [4] from Dow Jones
Related Articles:
Abbott's not finished with dealmaking [5]
Abbott's Miles White - CEO Pay [1]
Ranking pharma's highest-paid execs [6]
Links:
[1] http://www.fiercepharma.com/special-reports/abbotts-miles-white-ceo-pay
[2] http://www.fiercepharma.com/special-reports/bill-weldon-ceo-pay
[3] http://www.sec.gov/Archives/edgar/data/1800/000104746910002214/a2196602zdef14a.htm
[4] http://www.foxbusiness.com/story/markets/industries/industrials/abbott-ceo-whites-total-compensation-falls-/
[5] http://www.fiercepharma.com/story/abbotts-not-finished-dealmaking/2010-02-05
[6] http://www.fiercepharma.com/story/ranking-pharmas-highest-paid-execs/2009-04-03